Offered By
mylanoncostdClass Object ( [blocks_url] => https://learn.docmode.org/api/courses/v2/blocks/?course_id=course-v1%3Amylanonco%2BMNC0062%2B2022_Nov_MNC0062 [effort] => [end] => 2023-11-04T00:00:00Z [created] => 2022-11-02T12:37:17.960539Z [enrollment_start] => 2022-11-02T00:00:00Z [enrollment_end] => [id] => course-v1:mylanonco+MNC0062+2022_Nov_MNC0062 [media] => stdClass Object ( [course_image] => stdClass Object ( [uri] => /asset-v1:mylanonco+MNC0062+2022_Nov_MNC0062+type@asset+block@Lecture-card_04th_November_2022_Dr._Kumar_Rishikesh.png ) [course_video] => stdClass Object ( [uri] => ) [image] => stdClass Object ( [raw] => https://learn.docmode.org/asset-v1:mylanonco+MNC0062+2022_Nov_MNC0062+type@asset+block@Lecture-card_04th_November_2022_Dr._Kumar_Rishikesh.png [small] => https://learn.docmode.org/asset-v1:mylanonco+MNC0062+2022_Nov_MNC0062+type@asset+block@Lecture-card_04th_November_2022_Dr._Kumar_Rishikesh.png [large] => https://learn.docmode.org/asset-v1:mylanonco+MNC0062+2022_Nov_MNC0062+type@asset+block@Lecture-card_04th_November_2022_Dr._Kumar_Rishikesh.png ) ) [name] => Neo Adjuvant Therapy in Breast Cancer [number] => MNC0062 [org] => mylanonco [short_description] => [start] => 2022-11-04T09:00:00Z [start_display] => Nov. 4, 2022 [start_type] => timestamp [pacing] => instructor [mobile_available] => 1 [hidden] => [invitation_only] => [payment_url] => [course_type] => Lecture [course_price] => Free [other_courses] => Array ( [0] => stdClass Object ( [course_title] => Use Of Eribulin In The Management Of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00120+2024_Feb_MNC00120+type@asset+block@Lecture-card_05-february-2024_Dr.-AMIT-KUMAR-0000.jpg [wp_url] => https://docmode.org/use-of-eribulin-in-the-management-of-tnbc-dr-amit-kumar [course_type] => Lecture [start] => Feb 05, 2024 ) [1] => stdClass Object ( [course_title] => Updates on Triple Negative Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00119+2023_Dec_MNC00119+type@asset+block@Lecture-card_27th_Dec_2023_Dr._Tanvi_Sood-01.png [wp_url] => https://docmode.org/updates-on-triple-negative-breast-cancer-dr-tanvi-sood [course_type] => Lecture [start] => Dec 27, 2023 ) [2] => stdClass Object ( [course_title] => Diagnosis And Treatment Advancement In B.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00118+2023_Oct_MNC00118+type@asset+block@Lecture-card_27october-2023_Dr.-Prathyush-V.jpg [wp_url] => https://docmode.org/diagnosis-and-treatment-advancement-in-breast-cancer-dr-prathyush-v [course_type] => Lecture [start] => Oct 27, 2023 ) [3] => stdClass Object ( [course_title] => Approach to TNBC Management with Nab Paclitaxel [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00117+2023_Oct_MNC00117+type@asset+block@Lecture-card_20-october-2023_Dr.-Deepak-Gupta.jpg [wp_url] => https://docmode.org/approach-to-tnbc-management-with-nab-paclitaxel-dr-deepak-gupta [course_type] => Lecture [start] => Oct 26, 2023 ) [4] => stdClass Object ( [course_title] => Updates on Triple Negative Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00114+2023_Oct_MNC00114+type@asset+block@Lecture-card_19_october_2023_Dr._Mukesh_Patekar-01-01updated.png [wp_url] => https://docmode.org/updates-on-triple-negative-breast-cancer-dr-mukesh-patekar [course_type] => Lecture [start] => Oct 19, 2023 ) [5] => stdClass Object ( [course_title] => Updates on CML Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00115+2023_Oct_MNC00115+type@asset+block@Lecture-card_17_october_2023_Dr._Nitin_Gupta-01.png [wp_url] => https://docmode.org/updates-on-cml-management-dr-nitin-gupta [course_type] => Lecture [start] => Oct 17, 2023 ) [6] => stdClass Object ( [course_title] => Updates on Triple Negative Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00113+2023_Oct_MNC00113+type@asset+block@Suhas_Krriti_Lecture_card.jpg [wp_url] => https://docmode.org/updates-on-triple-negative-breast-cancer-dr-suhas-kriti-singla [course_type] => Lecture [start] => Oct 16, 2023 ) [7] => stdClass Object ( [course_title] => Breast Cancer - Understanding Diagnosis .. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00116+2023_Oct_MNC00116+type@asset+block@Lecture-card_14-October-2023_Dr-Sreevalli.png [wp_url] => https://docmode.org/breast-cancer-understanding-diagnosis-and-treatment-advancements-dr-sreevalli [course_type] => Lecture [start] => Oct 14, 2023 ) [8] => stdClass Object ( [course_title] => Optimizing TKI Therapy for Management of CML [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00112+2023_Jun_MNC00112+type@asset+block@Lecture-card_22nd_June_2023_Dr_Sowmya_Mukherjee.jpg [wp_url] => https://docmode.org/optimizing-tki-therapy-for-management-of-cml-dr-sowmya-mukherjee [course_type] => Lecture [start] => Jun 23, 2023 ) [9] => stdClass Object ( [course_title] => Role of Nab-Paclitaxel in TNBC Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00111+2023_Jun_MNC00111+type@asset+block@Lecture-card_22nd_June_2023_Dr._Deepak_Gupta-01.png [wp_url] => https://docmode.org/role-of-nabpaclitaxel-in-tnbc-management-dr-deepak-gupta [course_type] => Lecture [start] => Jun 22, 2023 ) [10] => stdClass Object ( [course_title] => Her2+ve Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0093+2023_Apr_MNC0093+type@asset+block@asset-v1_mylanonco_MNC0093_2023_Apr_MNC0093_type_asset_block_02.jpg [wp_url] => https://docmode.org/her-2ve-breast-cancer-management [course_type] => Lecture [start] => Jun 06, 2023 ) [11] => stdClass Object ( [course_title] => Role of Bevacizumab & clinical updates i.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00107+2023_May_MNC00107+type@asset+block@lecture_card_naik.png [wp_url] => https://docmode.org/role-of-bevacizumab-and-clinical-updates-in-management-of-gbm-dr-radheshyam-naik [course_type] => Lecture [start] => Jun 02, 2023 ) [12] => stdClass Object ( [course_title] => Updates on HER2 + Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00110+2023_Jun_MNC00110+type@asset+block@Lecture-card_02nd_June_2023_Dr._Suhas_Kirti_Singla-01.png [wp_url] => https://docmode.org/updates-on-her2-positive-breast-cancer-dr-suhas-kirti-singla [course_type] => Lecture [start] => Jun 02, 2023 ) [13] => stdClass Object ( [course_title] => Updates on HER2 + Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00109+2023_May_MNC00109+type@asset+block@Lecture-card_30th_May_2023_Dr._Tanvi_Sood-01.png [wp_url] => https://docmode.org/updates-on-her-2-positive-breast-cancer-dr-tanvi-sood [course_type] => Lecture [start] => May 30, 2023 ) [14] => stdClass Object ( [course_title] => Updates in the management of her 2+ve Br.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00106+2023_May_MNC00106+type@asset+block@Lecture_Card_Dr._Mohit_Agarwal.png [wp_url] => https://docmode.org/updates-in-the-management-of-her-2-positive-breast-cancer-dr-mohit-agarwal [course_type] => Lecture [start] => May 29, 2023 ) [15] => stdClass Object ( [course_title] => Role of Bevacizumab & Clinical Updates i.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00108+2023_May_MNC00108+type@asset+block@Lecture-card_26th_May_2023_Dr._Ganesha_Dev_Vashishta-01.png [wp_url] => https://docmode.org/role-of-bevacizumab-and-clinical-updates-in-management-of-gbm-dr-ganesha-dev-vashishta [course_type] => Lecture [start] => May 26, 2023 ) [16] => stdClass Object ( [course_title] => Gynaecological Cancer Screening in India [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00103+2023_May_MNC00103+type@asset+block@Lecture-card_23rd_DR._PRATHYUSH_V-01.png [wp_url] => https://docmode.org/gynaecological-cancer-screening-in-india-dr-prathyush-v [course_type] => Lecture [start] => May 23, 2023 ) [17] => stdClass Object ( [course_title] => Her2+ve Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00105+2023_May_MNC00105+type@asset+block@Lecture-card_Dr._Kinjal.png [wp_url] => https://docmode.org/her-2ve-breast-cancer-management-dr-kinjal-shah [course_type] => Lecture [start] => May 23, 2023 ) [18] => stdClass Object ( [course_title] => Her2+ Metastatic Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00100+2023_May_MNC00100+type@asset+block@Lecture-card_22nd_Dr._Syed_Ismail-01.png [wp_url] => https://docmode.org/her-2-metastatic-breast-cancer-dr-syed-ismail [course_type] => Lecture [start] => May 22, 2023 ) [19] => stdClass Object ( [course_title] => Usage of Trastuzumab in First Line Treat.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00104+2023_May_MNC00104+type@asset+block@Lecture-card_19th_Dr._Kakali_Choudhury-01.png [wp_url] => https://docmode.org/usage-of-trastuzumab-in-first-line-treatment-of-her-2ve-breast-cancer-management [course_type] => Lecture [start] => May 19, 2023 ) [20] => stdClass Object ( [course_title] => Updates on Management of Early and Metas.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC00102+2023_May_MNC00102+type@asset+block@Lecture-card_18th_Dr._Mounika_Bopanna.png [wp_url] => https://docmode.org/updates-on-management-of-early-and-metastatic-breast-cancer-dr-mounika-bopanna [course_type] => Lecture [start] => May 18, 2023 ) [21] => stdClass Object ( [course_title] => Role of Eribulin in the 2L Treatment of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0098+2023_May_MNC0098+type@asset+block@Lecture-card_11th_May_2023_Dr._Chandrakanth_M_V-01.png [wp_url] => https://docmode.org/role-of-eribulin-in-the-2-l-treatment-of-tnbc-dr-chandrakanth-m-v [course_type] => Lecture [start] => May 11, 2023 ) [22] => stdClass Object ( [course_title] => Role of Bevacizumab & Clinical Updates i.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0097+2023_May_MNC0097+type@asset+block@Lecture-card_10th_May_2023_Dr._Mridul_Malhotra-01.png [wp_url] => https://docmode.org/role-of-bevacizumab-and-clinical-updates-in-management-of-gbm-dr-mridul-malhotra [course_type] => Lecture [start] => May 10, 2023 ) [23] => stdClass Object ( [course_title] => Management of Early-Stage HER2 + Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0096+2023_May_MNC0096+type@asset+block@Lecture-card_9th_May_2023_Dr._Nitish_Garg-01789456.png [wp_url] => https://docmode.org/management-of-early-stage-her2-breast-cancer-dr-nitish-garg [course_type] => Lecture [start] => May 09, 2023 ) [24] => stdClass Object ( [course_title] => Role of Trastuzumab in Treatment of Her2.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0095+2023_May_MNC0095+type@asset+block@Lecture-card_8th_May_2023_Dr._Akshay_Shah-01.png [wp_url] => https://docmode.org/role-of-trastuzumab-in-treatment-of-her2-ve-breast-cancer-dr-akshay-shah [course_type] => Lecture [start] => May 08, 2023 ) [25] => stdClass Object ( [course_title] => Management of HER2+ Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0094+2023_May_MNC0094+type@asset+block@Lecture-card_5th_May_2023_Dr._Pradip_Kumar_Mondal-01.png [wp_url] => https://docmode.org/management-of-her-2-breast-cancer-dr-pradip-kumar-mondal [course_type] => Lecture [start] => May 05, 2023 ) [26] => stdClass Object ( [course_title] => Role of Bevacizumab in CRC Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0092+2023_Apr_MNC0092+type@asset+block@Lecture-card_5th_May_2023_Dr._Deepak_Gupta-new.png [wp_url] => https://docmode.org/role-of-bevacizumab-in-crc-management-dr-deepak-gupta [course_type] => Lecture [start] => May 05, 2023 ) [27] => stdClass Object ( [course_title] => Role of Nab Paclitaxel in TNBC Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0090+2023_Apr_MNC0090+type@asset+block@Lecture-card_3rd_May_2023_Dr_B_S_Ankit_Nehra-0155555.png [wp_url] => https://docmode.org/role-of-nab-paclitaxel-in-tnbc-management-dr-b-s-ankit-nehra [course_type] => Lecture [start] => May 03, 2023 ) [28] => stdClass Object ( [course_title] => Her 2 +ve mBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0091+2023_Apr_MNC0091+type@asset+block@Lecture-card_26th_April_2023_Dr._Sunil_Chopade-01.png [wp_url] => https://docmode.org/her-2-positive-mbc-dr-sunil-chopade [course_type] => Lecture [start] => Apr 26, 2023 ) [29] => stdClass Object ( [course_title] => Colorectal Surgery [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0089+2023_Apr_MNC0089+type@asset+block@Lecture-card_26th_April_2023_Dr._Anil_Heroor-01.png [wp_url] => https://docmode.org/colorectal-surgery-dr-anil-heroor [course_type] => Lecture [start] => Apr 26, 2023 ) [30] => stdClass Object ( [course_title] => Role of Eribulin in TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0086+2023_Apr_MNC0086+type@asset+block@LC_20th_April_2023_Dr.-Sachin-Jain1122.jpg [wp_url] => https://docmode.org/role-of-eribulin-in-tnbc-dr-sachin-jain [course_type] => Lecture [start] => Apr 20, 2023 ) [31] => stdClass Object ( [course_title] => HER2+ Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0087+2023_Apr_MNC0087+type@asset+block@Lecture-card_18th_April_2023_Dr._Arnab_Bhattacharya-01556699.png [wp_url] => https://docmode.org/her2-breast-cancer-management-dr-arnab-bhattacharya [course_type] => Lecture [start] => Apr 18, 2023 ) [32] => stdClass Object ( [course_title] => Management of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0084+2023_Apr_MNC0084+type@asset+block@Lecture-card_13-Apr-2023_Dr._Sanath_K-01.png [wp_url] => https://docmode.org/management-of-tnbc-dr-sanath-k-1 [course_type] => Lecture [start] => Apr 13, 2023 ) [33] => stdClass Object ( [course_title] => Role of Dasatinib in the Management of CML [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0083+2023_Mar_MNC0083+type@asset+block@Lecture-card_7th_April_2023_Dr._Ankur_Mittal-01.png [wp_url] => https://docmode.org/role-of-dasatinib-in-the-management-of-cml-dr-ankur-mittal [course_type] => Lecture [start] => Apr 07, 2023 ) [34] => stdClass Object ( [course_title] => Role of Bosutinib in CML [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0085+2023_Apr_MNC0085+type@asset+block@Lecture-card_7th_April_2023_Dr._Sayan_Ghoshal-01.png [wp_url] => https://docmode.org/role-of-bosutinib-in-cml-dr-sayan-ghoshal [course_type] => Lecture [start] => Apr 07, 2023 ) [35] => stdClass Object ( [course_title] => Management of Prostate Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0078+2023_Mar_MNC0078+type@asset+block@Lecture-card_5th_April_2023_Dr._Rakesh_Sharma-01.png [wp_url] => https://docmode.org/management-of-prostate-cancer-dr-rakesh-sharma [course_type] => Lecture [start] => Apr 05, 2023 ) [36] => stdClass Object ( [course_title] => General Cancer Awareness [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0082+2023_Mar_MNC0082+type@asset+block@Lecture-card_30-March-2023_Dr._Mukesh_Bansal-01.png [wp_url] => https://docmode.org/general-cancer-awareness-dr-mukesh-bansal [course_type] => Lecture [start] => Mar 30, 2023 ) [37] => stdClass Object ( [course_title] => Updates on Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0077+2023_Mar_MNC0077+type@asset+block@Lecture-card_25th-_March-2023_Dr_Rahul_Kulkarni_V2.jpg [wp_url] => https://docmode.org/updates-on-breast-cancer-management-dr-rahul-kulkarni [course_type] => Lecture [start] => Mar 27, 2023 ) [38] => stdClass Object ( [course_title] => Utilization, User Characteristics and Ad.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0081+2023_Mar_MNC0081+type@asset+block@Lecture-card_13th_March_2023_Dr_Mohit_Agarwal-022551.png [wp_url] => https://docmode.org/utilization-user-characteristics-and-adverse-outcomes-of-bevacizumab-products-in-oncology-dr-mohit-agarwal [course_type] => Lecture [start] => Mar 27, 2023 ) [39] => stdClass Object ( [course_title] => Bevacizumab viz a viz Targeted Therapies.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0080+2023_Mar_MNC0080+type@asset+block@Lecture-card_21-_March-2023_Dr_Arun_Ramanan_V-01.png [wp_url] => https://docmode.org/bevacizumab-viz-a-viz-targeted-therapies-in-metastatic-colorectal-cancer-dr-arun-ramanan-v [course_type] => Lecture [start] => Mar 21, 2023 ) [40] => stdClass Object ( [course_title] => Screening and Early Diagnosis of Colon Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0079+2023_Mar_MNC0079+type@asset+block@Lecture-card_10th_March_2023_Dr._Adil_Hasaan-01.png [wp_url] => https://docmode.org/screening-and-early-diagnosis-of-colon-cancer-dr-adil-hasaan [course_type] => Lecture [start] => Mar 10, 2023 ) [41] => stdClass Object ( [course_title] => Recent Updates in TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0076+2023_Mar_MNC0076+type@asset+block@Lecture-card_06-_March-2023_Dr._Saurabh_Mishra-01.png [wp_url] => https://docmode.org/recent-updates-in-tnbc-dr-saurabh-mishra [course_type] => Lecture [start] => Mar 06, 2023 ) [42] => stdClass Object ( [course_title] => Role of Trastuzumab in MBC Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0072+2023_Feb_MNC0072+type@asset+block@Lecture-card_28th_Feb_2023_Dr._Vinay_Vyas-01.png [wp_url] => https://docmode.org/role-of-trastuzumab-in-mbc-management-dr-vinay-vyas [course_type] => Lecture [start] => Feb 28, 2023 ) [43] => stdClass Object ( [course_title] => Management of HER2+ve Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0075+2023_Feb_MNC0075+type@asset+block@Lecture-card_27th_Feb_2023_Dr._Sanath_K-02.png [wp_url] => https://docmode.org/management-of-her2-ve-bc-dr-sanath-k [course_type] => Lecture [start] => Feb 27, 2023 ) [44] => stdClass Object ( [course_title] => Role of Front - Line Bevacizumab in Adva.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0074+2023_Feb_MNC0074+type@asset+block@Lecture_Dr._Jyoti_Wadhwa-01.png [wp_url] => https://docmode.org/role-of-front-line-bevacizumab-in-advanced-ovarian-cancer-dr-jyoti-wadhwa [course_type] => Lecture [start] => Feb 25, 2023 ) [45] => stdClass Object ( [course_title] => Recent Updates on Her2neu+ve Breast Canc.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0073+2023_Feb_MNC0073+type@asset+block@Lecture-card_24th_Feb_2023_Dr._Kapil_Goyal-01.png [wp_url] => https://docmode.org/recent-updates-on-her2neu-ve-breast-cancer-and-its-updated-treatment-regimen-dr-kapil-goyal [course_type] => Lecture [start] => Feb 24, 2023 ) [46] => stdClass Object ( [course_title] => Management of Colorectal Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0071+2023_Jan_MNC0071+type@asset+block@Lecture-card_27th_Jan_2023_Dr._Sanath_K-01.png [wp_url] => https://docmode.org/management-of-colorectal-cancer-dr-sanath-k-2 [course_type] => Lecture [start] => Jan 27, 2023 ) [47] => stdClass Object ( [course_title] => Breast Cancer Management Recent Update o.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0070+2023_Jan_MNC0070+type@asset+block@Lecture-card_19th_Jan_2022_Dr._Vikas_Asati-01__1_.png [wp_url] => https://docmode.org/breast-cancer-management-recent-update-on-trastuzumab-dr-vikas-asati [course_type] => Lecture [start] => Jan 19, 2023 ) [48] => stdClass Object ( [course_title] => Role of Eribulin in the Management of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0069+2022_Dec_MNC0069+type@asset+block@Lecture-card_20th_December_2022_Dr._Jyoti_Wadhwa.png [wp_url] => https://docmode.org/role-of-eribulin-in-the-management-of-tnbc-dr-jyoti-wadhwa [course_type] => Lecture [start] => Dec 20, 2022 ) [49] => stdClass Object ( [course_title] => Management of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0067+2022_Dec_MNC0067+type@asset+block@Lecture-card_16th_December_2022_Dr._Sanath_K.png [wp_url] => https://docmode.org/management-of-tnbc-dr-sanath-k [course_type] => Lecture [start] => Dec 16, 2022 ) [50] => stdClass Object ( [course_title] => Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0068+2022_Dec_MNC0068+type@asset+block@Lecture-card_13th_December_2022_Dr._Rohit_Pai.png [wp_url] => https://docmode.org/breast-cancer-management-dr-rohit-pai [course_type] => Lecture [start] => Dec 13, 2022 ) [51] => stdClass Object ( [course_title] => Current Updates in Lung Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0066+2022_Nov_MNC0066+type@asset+block@Lecture-card_6th_December___2022_Dr._Vikas_Goswami.png [wp_url] => https://docmode.org/current-updates-in-lung-cancer-management-dr-vikas-goswami [course_type] => Lecture [start] => Dec 06, 2022 ) [52] => stdClass Object ( [course_title] => Current Updates in Lung Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0065+2022_Nov_MNC0065+type@asset+block@Lecture-card_30th_November_2022_Dr._Rajat_Saha.png [wp_url] => https://docmode.org/current-updates-in-lung-cancer-management-dr-rajat-saha [course_type] => Lecture [start] => Nov 30, 2022 ) [53] => stdClass Object ( [course_title] => Management of Colorectal Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0063+2022_Nov_MNC0063+type@asset+block@Lecture-card_04th_November_2022_Dr._Sanath_K.png [wp_url] => https://docmode.org/management-of-colorectal-cancer-dr-sanath-k [course_type] => Lecture [start] => Nov 04, 2022 ) [54] => stdClass Object ( [course_title] => Neo Adjuvant Therapy in Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0062+2022_Nov_MNC0062+type@asset+block@Lecture-card_04th_November_2022_Dr._Kumar_Rishikesh.png [wp_url] => https://docmode.org/neo-adjuvant-therapy-in-breast-cancer-dr-kumar-rishikesh [course_type] => Lecture [start] => Nov 04, 2022 ) [55] => stdClass Object ( [course_title] => Sequence of treatment in management of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0060+2022_Oct_MNC0060+type@asset+block@Lecture-card_02nd_Nov_2022_Dr._Jyosthna.png [wp_url] => https://docmode.org/sequence-of-treatment-in-management-of-tnbc-dr-jyosthna-e [course_type] => Lecture [start] => Nov 02, 2022 ) [56] => stdClass Object ( [course_title] => Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0061+2022_Oct_MNC0061+type@asset+block@Lecture-card_31st_October_2022_Dr._Divesh_Goyal.png [wp_url] => https://docmode.org/breast-cancer-management-dr-divesh-goyal [course_type] => Lecture [start] => Oct 31, 2022 ) [57] => stdClass Object ( [course_title] => Breast Cancer Awareness [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0059+2022_Oct_MNC0059+type@asset+block@Lecture-card_27th_October_2022_Dr._Yogesh_Nischal-01.png [wp_url] => https://docmode.org/breast-cancer-awareness-dr-yogesh-nischal [course_type] => Lecture [start] => Oct 27, 2022 ) [58] => stdClass Object ( [course_title] => Role of Eribulin in Management of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0058+2022_Oct_MNC0058+type@asset+block@Lecture-card_17th_October_2022_Dr._Akshay_Shah.png [wp_url] => https://docmode.org/role-of-eribulin-in-management-of-tnbc-dr-akshay-shah [course_type] => Lecture [start] => Oct 17, 2022 ) [59] => stdClass Object ( [course_title] => Cancer Clinical Research [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0057+2022_Oct_MNC0057+type@asset+block@Lecture-card_12th_October_2022_Dr._Pankaj_Kumar_Panda.png [wp_url] => https://docmode.org/cancer-clinical-research-dr-pankaj-kumar-panda [course_type] => Lecture [start] => Oct 12, 2022 ) [60] => stdClass Object ( [course_title] => Awareness on Management of Her 2+ve Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0056+2022_Sep_MNC0056+type@asset+block@Lecture-card_01st_October_2022__Dr._Sanath_K.png [wp_url] => https://docmode.org/awareness-on-management-of-her-2-ve-breast-cancer-dr-sanath-k [course_type] => Lecture [start] => Oct 01, 2022 ) [61] => stdClass Object ( [course_title] => Gynaecological Cancer Updates [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0055+2022_Sep_MNC0055+type@asset+block@Lecture-card_30th_September_2022_Dr._Kiran_Kumar_DVS.png [wp_url] => https://docmode.org/gynaecological-cancer-updates-dr-kiran-kumar-dvs [course_type] => Lecture [start] => Sep 30, 2022 ) [62] => stdClass Object ( [course_title] => Role of Nab Paclitaxel in Breast Malignancy [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0054+2022_Sep_MNC0054+type@asset+block@Lecture-card_29th_September_2022_Dr._Navneet_Tripathi__1_.png [wp_url] => https://docmode.org/role-of-nab-paclitaxel-in-breast-malignancy-dr-navneet-tripathi [course_type] => Lecture [start] => Sep 29, 2022 ) [63] => stdClass Object ( [course_title] => Role of Bevacizumab in Gynecological Malignancies [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0053+2022_Sep_MNC0053+type@asset+block@Lecture-card_28th_September_2022_Dr._Saurabh_Mishra.png [wp_url] => https://docmode.org/role-of-bevacizumab-in-gynecological-malignancies-dr-saurabh-mishra [course_type] => Lecture [start] => Sep 28, 2022 ) [64] => stdClass Object ( [course_title] => Awareness on Management of Ovarian Cance.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0052+2022_Sep_MNC0052+type@asset+block@Lecture-card_28th_September_2022_Dr._Kripa_Bajaj.png [wp_url] => https://docmode.org/awareness-on-management-of-ovarian-cancer-endometrial-cancer-and-cervical-cancer-dr-kripa-bajaj [course_type] => Lecture [start] => Sep 28, 2022 ) [65] => stdClass Object ( [course_title] => Role of Bevacizumab in Gynecological Malignancies [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0050+2022_Sep_MNC0050+type@asset+block@Lecture-card_27th_September_2022_Dr._Lalit_Sharma__2_.png [wp_url] => https://docmode.org/role-of-bevacizumab-in-gynecological-malignancies-dr-lalit-sharma [course_type] => Lecture [start] => Sep 27, 2022 ) [66] => stdClass Object ( [course_title] => Sequence of treatment in TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0051+2022_Sep_MNC0051+type@asset+block@Lecture-card_20th_September_2022_Dr._C_H_Shyny_Reddy__1_.png [wp_url] => https://docmode.org/sequence-of-treatment-in-tnbc-dr-c-h-shyny-reddy [course_type] => Lecture [start] => Sep 20, 2022 ) [67] => stdClass Object ( [course_title] => Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0049+2022_Sep_MNC0049+type@asset+block@Lecture-card_03rd_September_2022_Dr._Suparna_Rao.png [wp_url] => https://docmode.org/breast-cancer-management-dr-suparna-rao [course_type] => Lecture [start] => Sep 03, 2022 ) [68] => stdClass Object ( [course_title] => Recent Advance on the Role of Eribulin M.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0048+2022_Aug_MNC0048+type@asset+block@Lecture-card_22th_August_2022_Dr._Mukesh_Patekar.png [wp_url] => https://docmode.org/recent-advance-on-the-role-of-eribulin-mesylate-in-breast-cancer-dr-mukesh-patekar [course_type] => Lecture [start] => Aug 22, 2022 ) [69] => stdClass Object ( [course_title] => Early Stage TNBC : Update in Medical Therapeutics [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0047+2022_Aug_MNC0047+type@asset+block@Lecture-card_19th_August__2022_Dr._Peush_Bajpai.png [wp_url] => https://docmode.org/early-stage-tnbc-update-in-medical-therapeutics-dr-peush-bajpai [course_type] => Lecture [start] => Aug 19, 2022 ) [70] => stdClass Object ( [course_title] => Management of High-Risk Non-Metastatic P.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0046+2022_Jul_MNC0046+type@asset+block@Lecture-card_26th-July-2022_Dr.-Ajit-Saxena.jpg [wp_url] => https://docmode.org/management-of-high-risk-non-metastatic-prostate-cancer-dr-ajit-saxena [course_type] => Lecture [start] => Jul 26, 2022 ) [71] => stdClass Object ( [course_title] => Diagnostic Approach of Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0044+2022_Jul_MNC0044+type@asset+block@Lecture-card_23rd_July_2022_Dr._Nitish_Garg.jpg [wp_url] => https://docmode.org/diagnostic-approach-of-breast-cancer-dr-nitish-garg [course_type] => Lecture [start] => Jul 23, 2022 ) [72] => stdClass Object ( [course_title] => Acute Leukemia [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0045+2022_Jul_MNC0045+type@asset+block@Lecture-card_23rd-July-2022_Dr.-Akshay-Shah.jpg [wp_url] => https://docmode.org/acute-leukemia-dr-akshay-shah [course_type] => Lecture [start] => Jul 23, 2022 ) [73] => stdClass Object ( [course_title] => Sequencing of Treatment in Metastatic Tr.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0043+2022_Jul_MNC0043+type@asset+block@Lecture-card_21st_July__2022_Dr._Suhas_Kirti_Singla-01.jpg [wp_url] => https://docmode.org/sequencing-of-treatment-in-metastatic-triple-negative-breast-cancer-dr-suhas-kirt-singla [course_type] => Lecture [start] => Jul 21, 2022 ) [74] => stdClass Object ( [course_title] => Metastatic Colorectal Cancer (mCRC)- Cha.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0042+2022_Jun_MNC0042+type@asset+block@Lecture-card_07th_July_2022_Dr._Tanmoy_Kumar_Mandal-01.jpg [wp_url] => https://docmode.org/metastatic-colorectal-cancer-mcrc-challenges-opportunities-dr-tanmoy-kumar-mandal [course_type] => Lecture [start] => Jul 07, 2022 ) [75] => stdClass Object ( [course_title] => Triple Negative Breast Cancer Management (TNBC) [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0041+2022_Jun_MNC0041+type@asset+block@Lecture-card_05th_July_2022_Dr._Divesh_Goyal-01.jpg [wp_url] => https://docmode.org/triple-negative-breast-cancer-management-tnbc-dr-divyesh-goyal [course_type] => Lecture [start] => Jul 05, 2022 ) [76] => stdClass Object ( [course_title] => Landscape of Treatment of HER 2 Positive MBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0040+2022_Jun_MNC0040+type@asset+block@Lecture-card_25th_June_2022_Dr._Jyoti_Wadhwa-01.jpg [wp_url] => https://docmode.org/landscape-of-treatment-of-her-two-positive-mbc-dr-jyoti-wadhwa [course_type] => Lecture [start] => Jun 25, 2022 ) [77] => stdClass Object ( [course_title] => Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0039+2022_Jun_MNC0039+type@asset+block@Lecture-card_24th_June_2022_Dr._Priti_Agarwal-01.jpg [wp_url] => https://docmode.org/breast-cancer-management-dr-priti-agarwal [course_type] => Lecture [start] => Jun 24, 2022 ) [78] => stdClass Object ( [course_title] => Update on Gynecological Cancers [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0038+2022_Jun_MNC0038+type@asset+block@Lecture-card_22nd_June_2022_Dr._S._Suresh-01.jpg [wp_url] => https://docmode.org/update-on-gynecological-cancers-dr-s-suresh [course_type] => Lecture [start] => Jun 22, 2022 ) [79] => stdClass Object ( [course_title] => Update on Neo Adjuvant Non-Metastatic Tr.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0036+2022_Jun_MNC0036+type@asset+block@Lecture-card_08th_June_2022_Dr._Arun_Ramanan-01.jpg [wp_url] => https://docmode.org/update-on-neo-adjuvant-non-metastatic-triple-negative-breast-cancer-dr-arun-ramanan [course_type] => Lecture [start] => Jun 08, 2022 ) [80] => stdClass Object ( [course_title] => Breast Cancer Awareness [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0037+2022_Jun_MNC0037+type@asset+block@Lecture-card_04th_June_2022_Dr._Animesh_Saha-01.jpg [wp_url] => https://docmode.org/breast-cancer-awareness-dr-animesh-saha [course_type] => Lecture [start] => Jun 04, 2022 ) [81] => stdClass Object ( [course_title] => Metastatic Colo Rectal Cancer - Opportun.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0035+2022_May_MNC0035+type@asset+block@Lecture-card_02nd_June_2022-01.jpg [wp_url] => https://docmode.org/metastatic-colo-rectal-cancer-opportunities-and-challenges-dr-naba-kumar-kalita [course_type] => Lecture [start] => Jun 02, 2022 ) [82] => stdClass Object ( [course_title] => Prostate Cancer Management (mCRPC) [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0031+2022_May_MNC0031+type@asset+block@Lecture-card_29th_May_2022_Dr._Rakesh_Sharma-01.jpg [wp_url] => https://docmode.org/prostate-cancer-management-mcrpc-dr-rakesh-sharma [course_type] => Lecture [start] => May 29, 2022 ) [83] => stdClass Object ( [course_title] => Role of Bevacizumab in Gynecological Malignancies [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0032+2022_May_MNC0032+type@asset+block@Lecture-card_26th_May_2022_Dr._Adil_Hassan-01.jpg [wp_url] => https://docmode.org/role-of-bevacizumab-in-gynecological-malignancies-dr-adil-hassan [course_type] => Lecture [start] => May 26, 2022 ) [84] => stdClass Object ( [course_title] => Prostate Cancer Update [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0033+2022_May_MNC0033+type@asset+block@Lecture-card_26th_May_2022_Dr._Mohammed_Naseer_R-01.jpg [wp_url] => https://docmode.org/prostate-cancer-update-dr-mohammed-naseer-r [course_type] => Lecture [start] => May 26, 2022 ) [85] => stdClass Object ( [course_title] => Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0034+2022_May_MNC0034+type@asset+block@Lecture-card_26th_May_2022_Dr._Sameeksha_Dubey-01.jpg [wp_url] => https://docmode.org/breast-cancer-management-dr-sameeksha-dubey [course_type] => Lecture [start] => May 26, 2022 ) [86] => stdClass Object ( [course_title] => HER-2+ve Breast cancer management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0030+2022_May_MNC0030+type@asset+block@Lecture-card_19th_May_2022_Dr._Kripa_Bajaj-01.jpg [wp_url] => https://docmode.org/her-two-positive-breast-cancer-management-dr-kripa-bajaj [course_type] => Lecture [start] => May 19, 2022 ) [87] => stdClass Object ( [course_title] => Neo Adjuvant Therapy in Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0028+2022_May_MNC0028+type@asset+block@Lecture-card_17th_May_2022_Dr._Saurabh_Prasad-01.jpg [wp_url] => https://docmode.org/neo-adjuvant-therapy-in-breast-cancer-dr-saurabh-prasad [course_type] => Lecture [start] => May 17, 2022 ) [88] => stdClass Object ( [course_title] => Recent Update on Triple Negative Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0029+2022_May_MNC0029+type@asset+block@Lecture-card_16th_May_2022_Dr._Syed_Ismail-01.jpg [wp_url] => https://docmode.org/recent-update-on-triple-negative-breast-cancer-dr-syed-ismail [course_type] => Lecture [start] => May 16, 2022 ) [89] => stdClass Object ( [course_title] => Basics of Cancer and Role of General Physicians [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0027+2022_May_MNC0027+type@asset+block@Lecture-card_09th_May_2022_Dr._Atul_Narayankar-01__2_.jpg [wp_url] => https://docmode.org/basics-of-cancer-and-role-of-general-physicians-dr-atul-narayankar [course_type] => Lecture [start] => May 09, 2022 ) [90] => stdClass Object ( [course_title] => Colorectal Cancer Awareness [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0025+2022_May_MNC0025+type@asset+block@Lecture-card_04th_May_2022_Dr._Bhanu_Prakash.jpg [wp_url] => https://docmode.org/colorectal-cancer-awareness-dr-bhanu-prakash-bandiamudi [course_type] => Lecture [start] => May 04, 2022 ) [91] => stdClass Object ( [course_title] => Updates on Mangaement of TNBC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0026+2022_May_MNC0026+type@asset+block@Lecture-card_03rd_May_2022_Dr._Sanath._K-01.jpg [wp_url] => https://docmode.org/updates-on-mangaement-of-tnbc-dr-sanath-k [course_type] => Lecture [start] => May 03, 2022 ) [92] => stdClass Object ( [course_title] => Update On Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0024+2022_Apr_MNC0024+type@asset+block@Lecture-card_29th_April_2022_Dr._Rajkumar-01.jpg [wp_url] => https://docmode.org/update-on-breast-cancer-dr-rajkumar [course_type] => Lecture [start] => Apr 29, 2022 ) [93] => stdClass Object ( [course_title] => Optimizing TKI Therapy in CML Treatment [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0022+2022_Apr_MNC0022+type@asset+block@Lecture-card_27th_April_2022_Dr._Shraddha_Thakkar-01__2_.jpg [wp_url] => https://docmode.org/optimizing-tki-therapy-in-cml-treatment-dr-shraddha-thakkar [course_type] => Lecture [start] => Apr 27, 2022 ) [94] => stdClass Object ( [course_title] => HER-2+ve Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0023+2022_Apr_MNC0023+type@asset+block@Lecture-card_22nd_April_2022_Dr._Rekha_Bansal.jpg [wp_url] => https://docmode.org/her-two-positive-breast-cancer-management-dr-rekha-bansal [course_type] => Lecture [start] => Apr 22, 2022 ) [95] => stdClass Object ( [course_title] => Awareness on Colorectal Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0021+2022_Apr_MNC0021+type@asset+block@Lecture_card_21st_April_2022_Dr_Mounika_Boppana.jpg [wp_url] => https://docmode.org/awareness-on-colorectal-cancer-dr-mounika-boppana [course_type] => Lecture [start] => Apr 21, 2022 ) [96] => stdClass Object ( [course_title] => Colorectal Cancer Awareness [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0020+2022_Mar_MNC0020+type@asset+block@Lecture-card_01st_April_2022_Dr._Sanath._K-01.jpg [wp_url] => https://docmode.org/colorectal-cancer-awareness-dr-sanath-k [course_type] => Lecture [start] => Apr 01, 2022 ) [97] => stdClass Object ( [course_title] => Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0019+2022_Mar_MNC0019+type@asset+block@Lecture-card_24th_March_2022_Dr._Minakshi_Mishra-01.jpg [wp_url] => https://docmode.org/breast-cancer-dr-minakshi-mishra [course_type] => Lecture [start] => Mar 24, 2022 ) [98] => stdClass Object ( [course_title] => Triple-Negative Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0018+2022_Mar_MNC0018+type@asset+block@Lecture-card_21st_March_2022_Dr._Sandeep_Kumar_Barik-01.jpg [wp_url] => https://docmode.org/triple-negative-breast-cancer-dr-sandeep-kumar-barik [course_type] => Lecture [start] => Mar 21, 2022 ) [99] => stdClass Object ( [course_title] => A Discussion on Women's Cancer in India [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0017+2022_Mar_MNC0017+type@asset+block@Lecture-card_08th_March_2022-01.jpg [wp_url] => https://docmode.org/a-discussion-on-womens-cancer-in-india-dr-priya-tiwari [course_type] => Lecture [start] => Mar 08, 2022 ) [100] => stdClass Object ( [course_title] => Role of Anti VEGF & Anti EGFR therapy in mCRC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0016+2022_Mar_MNC0016+type@asset+block@Lecture-card_05th_March_2022_Dr._Sai_Vivek-01.jpg [wp_url] => https://docmode.org/role-of-anti-vegf-and-anti-egfr-therapy-in-mcrc-dr-sai-vivek [course_type] => Lecture [start] => Mar 05, 2022 ) [101] => stdClass Object ( [course_title] => HCC & Role of Lenvatinib in HCC [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0014+2022_Feb_MNC0014+type@asset+block@Lecture-card_04th_Mar_2022_Dr._P_N_Rao-01.jpg [wp_url] => https://docmode.org/hcc-and-role-of-lenvatinib-in-hcc-dr-p-n-rao [course_type] => Lecture [start] => Mar 04, 2022 ) [102] => stdClass Object ( [course_title] => Colorectal Cancer Awareness [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0015+2022_Feb_MNC0015+type@asset+block@Lecture-card_23rd_Feb_2022_Dr._Pallavi_Ladda-01.jpg [wp_url] => https://docmode.org/colorectal-cancer-awareness-dr-pallavi-ladda [course_type] => Lecture [start] => Feb 23, 2022 ) [103] => stdClass Object ( [course_title] => Gram (negative) infections in Hematologi.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0013+2022_Feb_MNC0013+type@asset+block@Lecture-card__22nd_February_2022_Dr._Santanu_Bagchi-01.jpg [wp_url] => https://docmode.org/gram-negative-infections-in-hematological-malignancies-dr-santanu-bagchi [course_type] => Lecture [start] => Feb 22, 2022 ) [104] => stdClass Object ( [course_title] => HER-2+ve Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0012+2022_Feb_MNC0012+type@asset+block@Lecture-card_18th_Feb_2022_Dr._S_V_S_S_Prasad-01.jpg [wp_url] => https://docmode.org/her-two-positive-breast-cancer-management-dr-s-v-s-s-prasad [course_type] => Lecture [start] => Feb 18, 2022 ) [105] => stdClass Object ( [course_title] => Current perspectives in TKI selection fo.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0010+2022_Feb_MNC0010+type@asset+block@Lecture-card_12th_Feb_2022Dr._Girish_V_Badarkhe-01__1_.jpg [wp_url] => https://docmode.org/current-perspectives-in-tki-selection-for-the-effective-management-of-cml-dr-girish-v-badarkhe [course_type] => Lecture [start] => Feb 17, 2022 ) [106] => stdClass Object ( [course_title] => Role of Bevacizumab in Gynaecological Malignancy. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC0011+2022_Feb_MNC0011+type@asset+block@Lecture-card_15th_Feb_2022_Dr._Kiran_Kumar_Sajjan_Shetty-01.jpg [wp_url] => https://docmode.org/role-of-bevacizumab-in-gynaecological-malignancy-dr-kiran-kumar-sajjan-shetty [course_type] => Lecture [start] => Feb 15, 2022 ) [107] => stdClass Object ( [course_title] => HER- 2 Positive Breast Cancer Advanced Disease [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC003+2022_Jan_MNC003+type@asset+block@Lecture-card_05th_Feb_2022_Dr._Aju_Mathew-01.jpg [wp_url] => https://docmode.org/her-two-positive-breast-cancer-advanced-disease-dr-aju-mathew [course_type] => Lecture [start] => Feb 05, 2022 ) [108] => stdClass Object ( [course_title] => HER-2+ve Breast cancer management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC009+2022_Feb_MNC009+type@asset+block@Lecture-card_04th_February_2022_Dr._Srinivas_Chakravarthy_G.-01.jpg [wp_url] => https://docmode.org/her-two-positive-breast-cancer-management-dr-srinivas-chakravarthy-g [course_type] => Lecture [start] => Feb 04, 2022 ) [109] => stdClass Object ( [course_title] => Her 2 Positive Breast Cancer - Advanced Disease [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC008+2022_Feb_MNC008+type@asset+block@Lecture-card_03rd_Feb_2022_Dr._Aparna_Sreevatsa-01.jpg [wp_url] => https://docmode.org/her-two-positive-breast-cancer-advanced-disease-dr-aparna-sreevatsa [course_type] => Lecture [start] => Feb 03, 2022 ) [110] => stdClass Object ( [course_title] => Common Cancers in India for Primary Care.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC007+2022_Feb_MNC007+type@asset+block@Lecture-card_02_Feb_2022-01__1_.jpg [wp_url] => https://docmode.org/common-cancers-in-india-for-primary-care-physicians-dr-r-ranga-rao [course_type] => Lecture [start] => Feb 02, 2022 ) [111] => stdClass Object ( [course_title] => Approach to CML: Diagnosis Evaluation, M.. [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC006+2022_Jan_MNC006+type@asset+block@Lecture-card_25th_Jan_2022_Dr._Gaurav_Dixit-01.jpg [wp_url] => https://docmode.org/approach-to-cml-diagnosis-evaluation-management-recent-advances-dr-gaurav-dixit [course_type] => Lecture [start] => Jan 25, 2022 ) [112] => stdClass Object ( [course_title] => Recent Advances in the Management of Breast Cancer [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC004+2022_Jan_MNC004+type@asset+block@Lecture-card_24th_Jan_2022_Dr._Sanath._K-01.jpg [wp_url] => https://docmode.org/recent-advances-in-the-management-of-breast-cancer-dr-sanath-k [course_type] => Lecture [start] => Jan 24, 2022 ) [113] => stdClass Object ( [course_title] => Role of Meropenem in Febrile Neutropenia [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC005+2022_Jan_MNC005+type@asset+block@Lecture-card_24th_Jan_2022_Dr._Sai_Vivek_Velkuru-01.jpg [wp_url] => https://docmode.org/role-of-meropenem-in-febrile-neutropenia-dr-sai-vivek-velkuru [course_type] => Lecture [start] => Jan 24, 2022 ) [114] => stdClass Object ( [course_title] => Overview On Breast Cancer Management [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC002+2022_Jan_MNC002+type@asset+block@Lecture-card_03rd_January_2022-01.jpg [wp_url] => https://docmode.org/overview-on-breast-cancer-management-dr-c-s-rao [course_type] => Lecture [start] => Jan 03, 2022 ) [115] => stdClass Object ( [course_title] => Overview on Gynecological Malignancies in India [org] => Mylan Onco [media] => /asset-v1:mylanonco+MNC001+2021_Sep_MNC001+type@asset+block@Lecture-card_27th_Sept_2021-01.jpg [wp_url] => https://docmode.org/overview-on-gynecological-malignancies-in-india-dr-vishwajeeth-k-pai [course_type] => Lecture [start] => Sep 27, 2021 ) ) [disclaimer] => Array ( ) [conversion_rate] => 70 [course_id] => course-v1:mylanonco+MNC0062+2022_Nov_MNC0062 [overview] =>)Information:
Price : FreeType : LectureMeet the instructor:
Dr. Kumar Rishikesh
Senior Consultant,
Medical Oncologist,
Apollo Hospital, Delhi.Frequently Asked Questions
The DocMode platform runs on the following browsers: Firefox, Chrome, Safari and Internet Explorer We generally encourage the use of, and fully support only, the latest version.
You only require a working computer/laptop/mobile and a stable internet connection and good audio (internal or external speakers, earphones or headset).
No. It is absolutely free of cost.
Yes, you can access the live lecture at a later date from your dashboard itself if you are enrolled for the same. Even if you haven’t enrolled for it, all live lectures hosted on DocMode.org are available for viewing under the Lectures section of the DocMode homepage.
There is a Question box just below the video player where you can submit any related questions at the time of the live lectures. Answering to the questions solely depends on the doctor/lecturer giving the lecture.
As per our policies with the doctor/lecturer the content used in the live lectures can be viewed only on DocMode.org
Information regarding any upcoming live lectures are put up on the site a week prior and can be found on our site’s homepage under Upcoming Lectures.
As of now DocMode does not offer any credit points for watching the live lectures/on-demand recording.
If you have a suggestion for a live lecture, you can email us at partner@docmode.org with your contact details along with your or speaker’s updated bio and details regarding the lecture with topics you wish to be covered.
Senior Consultant,
Medical Oncologist,
Apollo Hospital, Delhi.
The DocMode platform runs on the following browsers: Firefox, Chrome, Safari and Internet Explorer We generally encourage the use of, and fully support only, the latest version.
You only require a working computer/laptop/mobile and a stable internet connection and good audio (internal or external speakers, earphones or headset).
No. It is absolutely free of cost.
Yes, you can access the live lecture at a later date from your dashboard itself if you are enrolled for the same. Even if you haven’t enrolled for it, all live lectures hosted on DocMode.org are available for viewing under the Lectures section of the DocMode homepage.
There is a Question box just below the video player where you can submit any related questions at the time of the live lectures. Answering to the questions solely depends on the doctor/lecturer giving the lecture.
As per our policies with the doctor/lecturer the content used in the live lectures can be viewed only on DocMode.org
Information regarding any upcoming live lectures are put up on the site a week prior and can be found on our site’s homepage under Upcoming Lectures.
As of now DocMode does not offer any credit points for watching the live lectures/on-demand recording.
If you have a suggestion for a live lecture, you can email us at partner@docmode.org with your contact details along with your or speaker’s updated bio and details regarding the lecture with topics you wish to be covered.